1. Home
  2. SABS vs PSHG Comparison

SABS vs PSHG Comparison

Compare SABS & PSHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABS
  • PSHG
  • Stock Information
  • Founded
  • SABS 2014
  • PSHG 2010
  • Country
  • SABS United States
  • PSHG Greece
  • Employees
  • SABS N/A
  • PSHG N/A
  • Industry
  • SABS Biotechnology: Pharmaceutical Preparations
  • PSHG Marine Transportation
  • Sector
  • SABS Health Care
  • PSHG Consumer Discretionary
  • Exchange
  • SABS Nasdaq
  • PSHG Nasdaq
  • Market Cap
  • SABS 23.9M
  • PSHG 24.2M
  • IPO Year
  • SABS N/A
  • PSHG N/A
  • Fundamental
  • Price
  • SABS $3.10
  • PSHG $1.94
  • Analyst Decision
  • SABS Strong Buy
  • PSHG Strong Buy
  • Analyst Count
  • SABS 5
  • PSHG 1
  • Target Price
  • SABS $12.40
  • PSHG $6.50
  • AVG Volume (30 Days)
  • SABS 78.1K
  • PSHG 71.0K
  • Earning Date
  • SABS 11-06-2024
  • PSHG 11-07-2024
  • Dividend Yield
  • SABS N/A
  • PSHG N/A
  • EPS Growth
  • SABS N/A
  • PSHG N/A
  • EPS
  • SABS N/A
  • PSHG 1.51
  • Revenue
  • SABS $1,512,723.00
  • PSHG $89,608,000.00
  • Revenue This Year
  • SABS N/A
  • PSHG N/A
  • Revenue Next Year
  • SABS N/A
  • PSHG $2.66
  • P/E Ratio
  • SABS N/A
  • PSHG $1.29
  • Revenue Growth
  • SABS N/A
  • PSHG N/A
  • 52 Week Low
  • SABS $2.16
  • PSHG $1.70
  • 52 Week High
  • SABS $9.72
  • PSHG $2.58
  • Technical
  • Relative Strength Index (RSI)
  • SABS 48.28
  • PSHG 45.55
  • Support Level
  • SABS $3.17
  • PSHG $1.95
  • Resistance Level
  • SABS $3.74
  • PSHG $2.04
  • Average True Range (ATR)
  • SABS 0.48
  • PSHG 0.08
  • MACD
  • SABS -0.04
  • PSHG -0.01
  • Stochastic Oscillator
  • SABS 17.53
  • PSHG 33.87

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About PSHG Performance Shipping Inc.

Performance Shipping Inc is a provider of shipping transportation services through its ownership of tanker vessels. The company's vessels are employed on time charters with liner companies carrying containerized cargo along various shipping routes. It owns and operates eight Aframax tanker vessels.

Share on Social Networks: